دورية أكاديمية

Factors associated with the clinical outcome of patients with relapsed/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy

التفاصيل البيبلوغرافية
العنوان: Factors associated with the clinical outcome of patients with relapsed/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
المؤلفون: Ortiz-Maldonado, Valentín, Rives, Susana, Español-Rego, Marta, Alonso-Saladrigues, Anna, Montoro, Mercedes, Magnano, Laura, Giné, Eva, Pascal, Mariona, Díaz-Beyá, Marina, Castella, Maria, Català, Albert, Faura, Anna, Rodríguez-Lobato, Luis Gerardo, Oliver-Caldes, Aina, Martínez-Roca, Alexandra, Rovira, Montserrat, González-Navarro, E Azucena, Ortega, Juan Ramón, Cid, Joan, Lozano, Miquel, Garcia-Rey, Enric, Fernández, Sara, Castro, Pedro, Jordan, Iolanda, Villamor, Neus, Aymerich, Marta, Torrebadell, Montserrat, Deyà, Àngela, Fernández de Larrea, Carlos, Benitez-Ribas, Daniel, Trias, Esteve, Varea, Sara, Calvo, Gonzalo, Esteve, Jordi, Urbano-Ispizua, Alvaro, Juan, Manel, Delgado, Julio
المساهمون: Instituto de Salud Carlos III, Departament d'Universitats, Recerca i Societat de la Informació
المصدر: Journal for ImmunoTherapy of Cancer ; volume 9, issue 12, page e003644 ; ISSN 2051-1426
بيانات النشر: BMJ
سنة النشر: 2021
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1136/jitc-2021-003644
الإتاحة: https://doi.org/10.1136/jitc-2021-003644Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.BB2C1677
قاعدة البيانات: BASE